Listed

Propanc Biopharma, Inc.

PPCBNasdaqCIK 1517681HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$3.5m, Q4 FY2026
Net income−$4.6m, Q4 FY2026
Propanc Biopharma, Inc., income statement, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m0.0Research and development, Q1 FY2024, three months to 2023-09-30$16.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure0.1Research and development, Q2 FY2024, three months to 2023-12-31$114.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure0.1Research and development, Q3 FY2024, three months to 2024-03-31$65.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure0.1Research and development, Q4 FY2024, three months to 2024-06-30$52.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-09-29, accession 0001493152-25-016069. Derived: 12-month figure less the 9-month figure.Report this figure0.1Research and development, Q1 FY2025, three months to 2024-09-30$61.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure0.1Research and development, Q2 FY2025, three months to 2024-12-31$54.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure0.1Research and development, Q3 FY2025, three months to 2025-03-31$54.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure0.1Research and development, Q4 FY2025, three months to 2025-06-30$53.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure0.1Research and development, Q1 FY2026, three months to 2025-09-30$60.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure0.0Research and development, Q2 FY2026, three months to 2025-12-31$20.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure0.2Research and development, Q3 FY2026, three months to 2026-03-31$169.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure0.4Research and development, Q4 FY2026, three months to 2026-06-30$375.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$m(0.4)Operating income, Q1 FY2024, three months to 2023-09-30−$417.2k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure(0.4)Operating income, Q2 FY2024, three months to 2023-12-31−$438.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure(0.4)Operating income, Q3 FY2024, three months to 2024-03-31−$420.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(0.3)Operating income, Q4 FY2024, three months to 2024-06-30−$259.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-29, accession 0001493152-25-016069. Derived: 12-month figure less the 9-month figure.Report this figure(0.3)Operating income, Q1 FY2025, three months to 2024-09-30−$290.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure(0.2)Operating income, Q2 FY2025, three months to 2024-12-31−$213.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure(53.1)Operating income, Q3 FY2025, three months to 2025-03-31−$53.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(3.6)Operating income, Q4 FY2025, three months to 2025-06-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure(4.7)Operating income, Q1 FY2026, three months to 2025-09-30−$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure(3.7)Operating income, Q2 FY2026, three months to 2025-12-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure(6.4)Operating income, Q3 FY2026, three months to 2026-03-31−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(3.5)Operating income, Q4 FY2026, three months to 2026-06-30−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$m0.2Interest expense, Q1 FY2024, three months to 2023-09-30$178.2k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure0.3Interest expense, Q2 FY2024, three months to 2023-12-31$264.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-03-31$133.1k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-06-30$90.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-09-29, accession 0001493152-25-016069. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2024-09-30$86.2k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure0.1Interest expense, Q2 FY2025, three months to 2024-12-31$118.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure0.1Interest expense, Q3 FY2025, three months to 2025-03-31$104.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure0.3Interest expense, Q4 FY2025, three months to 2025-06-30$254.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2026, three months to 2025-09-30$305.6k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure0.1Interest expense, Q2 FY2026, three months to 2025-12-31$59.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure0.0Interest expense, Q3 FY2026, three months to 2026-03-31$38.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure0.0Interest expense, Q4 FY2026, three months to 2026-06-30$27.7k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure
Income tax$mnot reported(0.1)Income tax, Q2 FY2024, three months to 2023-12-31−$128.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure(0.0)Income tax, Q3 FY2024, three months to 2024-03-31−$275. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-06-30−$237. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-09-29, accession 0001493152-25-016069. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(0.4)Net income, Q1 FY2024, three months to 2023-09-30−$350.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(0.6)Net income, Q2 FY2024, three months to 2023-12-31−$584.4k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(0.5)Net income, Q3 FY2024, three months to 2024-03-31−$526.7k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(0.4)Net income, Q4 FY2024, three months to 2024-06-30−$358.6k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-29, accession 0001493152-25-016069. Derived: 12-month figure less the 9-month figure.Report this figure(0.4)Net income, Q1 FY2025, three months to 2024-09-30−$354.3k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(0.4)Net income, Q2 FY2025, three months to 2024-12-31−$430.2k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(54.1)Net income, Q3 FY2025, three months to 2025-03-31−$54.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(4.1)Net income, Q4 FY2025, three months to 2025-06-30−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure(4.8)Net income, Q1 FY2026, three months to 2025-09-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(3.1)Net income, Q2 FY2026, three months to 2025-12-31−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(6.4)Net income, Q3 FY2026, three months to 2026-03-31−$6.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(4.6)Net income, Q4 FY2026, three months to 2026-06-30−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(0.04)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure(1559.55)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$1559.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure(545.79)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$545.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figurenot reported(35.97)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$35.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure(32.23)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$32.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure(12.50)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$12.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figurenot reported(0.39)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure(0.30)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure(0.28)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figurenot reported
Basic EPS$ per share(0.04)Basic EPS, Q1 FY2024, three months to 2023-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure(1559.55)Basic EPS, Q2 FY2024, three months to 2023-12-31−$1559.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure(545.79)Basic EPS, Q3 FY2024, three months to 2024-03-31−$545.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figurenot reported(35.97)Basic EPS, Q1 FY2025, three months to 2024-09-30−$35.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure(32.23)Basic EPS, Q2 FY2025, three months to 2024-12-31−$32.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure(12.50)Basic EPS, Q3 FY2025, three months to 2025-03-31−$12.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figurenot reported(0.39)Basic EPS, Q1 FY2026, three months to 2025-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure(0.30)Basic EPS, Q2 FY2026, three months to 2025-12-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure(0.28)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figurenot reported

Balance sheet

Cash and equivalents$832.0k, FY2026
Long-term debt$55.0k, Q3 FY2026
Shareholders' equity$9.4m, FY2026
Propanc Biopharma, Inc., balance sheet, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m0.0Cash and equivalents, Q1 FY2024, at 2023-09-30$6.6k. XBRL concept us-gaap:Cash. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure0.1Cash and equivalents, Q2 FY2024, at 2023-12-31$71.7k. XBRL concept us-gaap:Cash. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure0.0Cash and equivalents, Q3 FY2024, at 2024-03-31$6.2k. XBRL concept us-gaap:Cash. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure0.0Cash and equivalents, FY2024, at 2024-06-30$21.1k. XBRL concept us-gaap:Cash. 10-K filed 2025-09-29, accession 0001493152-25-016069.Report this figure0.0Cash and equivalents, Q1 FY2025, at 2024-09-30$9.3k. XBRL concept us-gaap:Cash. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure0.0Cash and equivalents, Q2 FY2025, at 2024-12-31$14.6k. XBRL concept us-gaap:Cash. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure0.1Cash and equivalents, Q3 FY2025, at 2025-03-31$50.8k. XBRL concept us-gaap:Cash. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure0.0Cash and equivalents, FY2025, at 2025-06-30$12.1k. XBRL concept us-gaap:Cash. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure0.6Cash and equivalents, Q1 FY2026, at 2025-09-30$602.7k. XBRL concept us-gaap:Cash. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure0.6Cash and equivalents, Q2 FY2026, at 2025-12-31$561.2k. XBRL concept us-gaap:Cash. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure0.4Cash and equivalents, Q3 FY2026, at 2026-03-31$443.7k. XBRL concept us-gaap:Cash. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure0.8Cash and equivalents, FY2026, at 2026-06-30$832.0k. XBRL concept us-gaap:Cash. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure
Current assets$m0.1Current assets, Q1 FY2024, at 2023-09-30$145.8k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure0.2Current assets, Q2 FY2024, at 2023-12-31$210.8k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure0.0Current assets, Q3 FY2024, at 2024-03-31$12.9k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure0.0Current assets, FY2024, at 2024-06-30$25.4k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-09-29, accession 0001493152-25-016069.Report this figure0.0Current assets, Q1 FY2025, at 2024-09-30$21.5k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure0.0Current assets, Q2 FY2025, at 2024-12-31$18.0k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure9.7Current assets, Q3 FY2025, at 2025-03-31$9.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure8.4Current assets, FY2025, at 2025-06-30$8.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure8.8Current assets, Q1 FY2026, at 2025-09-30$8.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure7.7Current assets, Q2 FY2026, at 2025-12-31$7.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure8.2Current assets, Q3 FY2026, at 2026-03-31$8.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure8.5Current assets, FY2026, at 2026-06-30$8.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure
Total assets$m0.2Total assets, Q1 FY2024, at 2023-09-30$180.4k. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure0.2Total assets, Q2 FY2024, at 2023-12-31$241.9k. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure0.0Total assets, Q3 FY2024, at 2024-03-31$37.3k. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure0.1Total assets, FY2024, at 2024-06-30$72.4k. XBRL concept us-gaap:Assets. 10-K filed 2025-09-29, accession 0001493152-25-016069.Report this figure0.1Total assets, Q1 FY2025, at 2024-09-30$63.6k. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure0.1Total assets, Q2 FY2025, at 2024-12-31$78.5k. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure22.5Total assets, Q3 FY2025, at 2025-03-31$22.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure19.6Total assets, FY2025, at 2025-06-30$19.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure18.0Total assets, Q1 FY2026, at 2025-09-30$18.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure15.1Total assets, Q2 FY2026, at 2025-12-31$15.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure14.3Total assets, Q3 FY2026, at 2026-03-31$14.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure12.8Total assets, FY2026, at 2026-06-30$12.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure
Current liabilities$m3.1Current liabilities, Q1 FY2024, at 2023-09-30$3.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure3.8Current liabilities, Q2 FY2024, at 2023-12-31$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure3.7Current liabilities, Q3 FY2024, at 2024-03-31$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure3.8Current liabilities, FY2024, at 2024-06-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-09-29, accession 0001493152-25-016069.Report this figure4.1Current liabilities, Q1 FY2025, at 2024-09-30$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure4.2Current liabilities, Q2 FY2025, at 2024-12-31$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure4.3Current liabilities, Q3 FY2025, at 2025-03-31$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure5.6Current liabilities, FY2025, at 2025-06-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure3.6Current liabilities, Q1 FY2026, at 2025-09-30$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure3.6Current liabilities, Q2 FY2026, at 2025-12-31$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure3.5Current liabilities, Q3 FY2026, at 2026-03-31$3.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure3.4Current liabilities, FY2026, at 2026-06-30$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure
Total liabilities$m3.2Total liabilities, Q1 FY2024, at 2023-09-30$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure3.8Total liabilities, Q2 FY2024, at 2023-12-31$3.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure3.7Total liabilities, Q3 FY2024, at 2024-03-31$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure3.9Total liabilities, FY2024, at 2024-06-30$3.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-09-29, accession 0001493152-25-016069.Report this figure4.2Total liabilities, Q1 FY2025, at 2024-09-30$4.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure4.2Total liabilities, Q2 FY2025, at 2024-12-31$4.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure4.4Total liabilities, Q3 FY2025, at 2025-03-31$4.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure5.7Total liabilities, FY2025, at 2025-06-30$5.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure3.6Total liabilities, Q1 FY2026, at 2025-09-30$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure3.7Total liabilities, Q2 FY2026, at 2025-12-31$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure3.5Total liabilities, Q3 FY2026, at 2026-03-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure3.4Total liabilities, FY2026, at 2026-06-30$3.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure
Long-term debt$m0.4Long-term debt, Q1 FY2024, at 2023-09-30$397.4k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure0.7Long-term debt, Q2 FY2024, at 2023-12-31$687.6k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure0.6Long-term debt, Q3 FY2024, at 2024-03-31$583.0k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure0.4Long-term debt, FY2024, at 2024-06-30$399.3k. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-09-29, accession 0001493152-25-016069.Report this figure0.4Long-term debt, Q1 FY2025, at 2024-09-30$381.8k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure0.4Long-term debt, Q2 FY2025, at 2024-12-31$409.8k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure0.4Long-term debt, Q3 FY2025, at 2025-03-31$438.6k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure0.5Long-term debt, FY2025, at 2025-06-30$537.9k. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure0.1Long-term debt, Q1 FY2026, at 2025-09-30$107.0k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure0.1Long-term debt, Q2 FY2026, at 2025-12-31$55.0k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure0.1Long-term debt, Q3 FY2026, at 2026-03-31$55.0k. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figurenot reported
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(3.0)Shareholders' equity, Q1 FY2024, at 2023-09-30−$3.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(3.6)Shareholders' equity, Q2 FY2024, at 2023-12-31−$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(3.7)Shareholders' equity, Q3 FY2024, at 2024-03-31−$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure(3.8)Shareholders' equity, FY2024, at 2024-06-30−$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure(4.1)Shareholders' equity, Q1 FY2025, at 2024-09-30−$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure(4.2)Shareholders' equity, Q2 FY2025, at 2024-12-31−$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure18.1Shareholders' equity, Q3 FY2025, at 2025-03-31$18.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure13.9Shareholders' equity, FY2025, at 2025-06-30$13.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure14.4Shareholders' equity, Q1 FY2026, at 2025-09-30$14.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure10.5Shareholders' equity, Q2 FY2026, at 2025-12-31$10.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure9.8Shareholders' equity, Q3 FY2026, at 2026-03-31$9.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure9.4Shareholders' equity, FY2026, at 2026-06-30$9.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure

Cash flow

Operating cash flow−$1.6m, Q4 FY2026
Capital expenditure$21, Q4 FY2026
Propanc Biopharma, Inc., cash flow, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$k(333)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$333.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure(239)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$238.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-14, accession 0001493152-25-006697. Derived: 6-month figure less the 3-month figure.Report this figure(103)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$102.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-010798. Derived: 9-month figure less the 6-month figure.Report this figure(260)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$260.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-29, accession 0001493152-25-016069. Derived: 12-month figure less the 9-month figure.Report this figure(236)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$235.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure18.7Operating cash flow, Q2 FY2025, three months to 2024-12-31$18.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001493152-26-007052. Derived: 6-month figure less the 3-month figure.Report this figure(96.2)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$96.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023210. Derived: 9-month figure less the 6-month figure.Report this figure(92.2)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$92.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure(1,939)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure(999)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$999.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001493152-26-007052. Derived: 6-month figure less the 3-month figure.Report this figure(1,142)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023210. Derived: 9-month figure less the 6-month figure.Report this figure(1,602)Operating cash flow, Q4 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported2.5Capital expenditure, Q1 FY2026, three months to 2025-09-30$2.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure2.3Capital expenditure, Q2 FY2026, three months to 2025-12-31$2.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001493152-26-007052. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2026, three months to 2026-03-31$154. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001493152-26-023210. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2026, three months to 2026-06-30$21. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-25, accession 0001493152-26-044373. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)22.43m, Q3 FY2026
Propanc Biopharma, Inc., shares, quarterly
Line itemUnitQ1 FY20232022-09-30Q2 FY20232022-12-31Q3 FY20232023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)m shares0.5Diluted shares (weighted), Q1 FY2023, three months to 2022-09-30473,589 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-040980.Report this figure1.0Diluted shares (weighted), Q2 FY2023, three months to 2022-12-31960,471 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-20, accession 0001493152-24-007191.Report this figure1.9Diluted shares (weighted), Q3 FY2023, three months to 2023-03-311,924,074 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001493152-24-019940.Report this figure11.0Diluted shares (weighted), Q1 FY2024, three months to 2023-09-3010,989,681 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-045664.Report this figure0.0Diluted shares (weighted), Q2 FY2024, three months to 2023-12-31397 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-14, accession 0001493152-25-006697.Report this figure0.0Diluted shares (weighted), Q3 FY2024, three months to 2024-03-31994 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-010798.Report this figure0.0Diluted shares (weighted), Q1 FY2025, three months to 2024-09-309,849 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure0.0Diluted shares (weighted), Q2 FY2025, three months to 2024-12-3113,347 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure4.3Diluted shares (weighted), Q3 FY2025, three months to 2025-03-314,325,994 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure12.3Diluted shares (weighted), Q1 FY2026, three months to 2025-09-3012,331,526 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001493152-25-023213.Report this figure13.4Diluted shares (weighted), Q2 FY2026, three months to 2025-12-3113,360,358 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001493152-26-007052.Report this figure22.4Diluted shares (weighted), Q3 FY2026, three months to 2026-03-3122,427,486 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023210.Report this figure

Shares outstanding: 6.33mShares outstanding, period not labelled, at 2026-09-236,331,116 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-09-25, accession 0001493152-26-044373.Report this figure at Sep 23, 2026, from the cover of the 10-K filed Sep 25, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.